TRIANNI and Antibody Discovery

Fully human monoclonal antibodies are powerful biological therapeutics.

Among many options available for isolating them, TRIANNI’s technology is distinguished by key advantages of ease of use, antibody diversity, and in vivo selection.


BioJapan 2016

October 12-14 | Pacifico Yokohama, Japan

AusBiotech 2016

October 24–26 | Victoria, Australia

PEGS Summit – Europe

PRESENTER | October 31–November 4 | Lisbon, Portugal